Showing results (121-130 of 175) with videos related to
Sort By:
Pageof 18
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor: The Okayama Lung Cancer Study Group Trial 1202Shoichi Kuyama, Nobuaki Ochi, Akihiro Bessho, et al.Journal of Cancer Research and Clinical Oncology|October 29, 2022
More than one-third of advanced non-small-cell lung cancer patients do not receive immunochemotherapy due to intoleranceChihiro Ando, Eiki Ichihara, Toshihide Yokoyama, et al.Lung Cancer (Amsterdam, Netherlands)|February 8, 2023
PD-1 blockade augments CD8<sup>+</sup> T cell dependent antitumor immunity triggered by Ad-SGE-REIC in Egfr-mutant lung cancerTakamasa Nakasuka, Kadoaki Ohashi, Kazuya Nishii, et al.Cureus|June 27, 2025
Association Between Initial Symptoms and Clinical Outcomes in COVID-19Eiki Ichihara, Toshiharu Mitsuhashi, Mitsuru Tsuge, et al.Cancers|December 17, 2024
Frequency and Significance of Body Weight Loss During Immunochemotherapy in Patients with Advanced Non-Small Cell Lung CancerMasataka Taoka, Eiki Ichihara, Toshihide Yokoyama, et al.International Journal of Molecular Sciences|August 10, 2024
Increased Oxidative Stress and Decreased Citrulline in Blood Associated with Severe Novel Coronavirus Pneumonia in Adult PatientsMitsuru Tsuge, Eiki Ichihara, Kou Hasegawa, et al.Journal of Thoracic Disease|June 17, 2024
Treatment rationale and protocol design: an investigator-initiated phase II study of combination treatment of nivolumab and TM5614, a PAI-1 inhibitor for previously treated patients with non-small cell lung cancerTakeshi Masuda, Taizo Hirata, Tomohiro Sakamoto, et al.Japanese Journal of Clinical Oncology|June 11, 2021
Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404Takashi Ninomiya, Naoyuki Nogami, Toshiyuki Kozuki, et al.Translational Lung Cancer Research|November 29, 2023
CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in <i>EGFR</i>-mutant non-small cell lung cancerNaofumi Hara, Eiki Ichihara, Hirohisa Kano, et al.Acta Oncologica (Stockholm, Sweden)|January 31, 2012
Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402Naoyuki Nogami, Katsuyuki Hotta, Yoshihiko Segawa, et al.Pageof 18